Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aligos Therapeutics Inc (NQ: ALGS )

1.080 -0.020 (-1.82%)
Streaming Delayed Price Updated: 12:48 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 211,508
Open 1.100
Bid (Size) 1.070 (7)
Ask (Size) 1.080 (3)
Prev. Close 1.100
Today's Range 1.070 - 1.180
52wk Range 1.030 - 34.31
Shares Outstanding 42,695,195
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022
Upgrades 
Via Benzinga
Where Aligos Therapeutics Stands With Analysts
Within the last quarter, Aligos Therapeutics (NASDAQ:ALGS) has observed the following analyst ratings: 
Via Benzinga

Performance

YTD
-91.15%
-91.15%
1 Month
-26.53%
-26.53%
3 Month
-54.62%
-54.62%
6 Month
-93.47%
-93.47%
1 Year
-95.30%
-95.30%

More News

Read More
Preview: Aligos Therapeutics's Earnings
Via Benzinga
NASDAQ: ALGS Investor Notice: Investigation over Potential Wrongdoing at Aligos Therapeutics, Inc.
Via SBWire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Aligos Pulls Plug On Early-Stage Chronic Hepatitis B Treatment Candidate
Via Benzinga
Earnings Scheduled For March 10, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
63 Biggest Movers From Yesterday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Via Benzinga
Recap: Aligos Therapeutics Q4 Earnings
Via Benzinga
Aligos Therapeutics Earnings Preview
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Via Benzinga
Can Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
SHAREHOLDER ALERT: Robbins LLP Investigates Aligos Therapeutics, Inc. (ALGS) on Behalf of Shareholders
From Robbins LLP
Via Business Wire
NASDAQ: ALGS Shareholder Notice: Investigation over Potential Securities Laws Violations by Aligos Therapeutics, Inc.
Via SBWire
ALIGOS ALERT: Bragar Eagel & Squire, P.C. is Investigating Aligos Therapeutics, Inc. on Behalf of Aligos Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
SHAREHOLDER ALERT: Robbins LLP Investigates Aligos Therapeutics, Inc. (ALGS) on Behalf of Shareholders
From Robbins LLP
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming
Via Benzinga
56 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
33 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.